Previous studies have shown that PSD95 was post-transcriptionally regulated at excitatory synapses and there are several neurological disorders, including AD, in which impairments in the normal function of PSD95 are associated with post-translational modifications [40]. The gene discussed is DLG4; the disease is Alzheimer disease.